|
Volumn 120, Issue 1-3, 2001, Pages 59-66
|
Assessment of biotechnology products for therapeutic use
|
Author keywords
Biotechnology; Pharmaceutical; Safety assessment
|
Indexed keywords
BLOOD CLOTTING FACTOR;
CYTOKINE;
DNA VACCINE;
ENZYME;
GROWTH FACTOR;
HORMONE;
MONOCLONAL ANTIBODY;
RECEPTOR;
RIBOZYME;
VACCINE;
ADOPTIVE IMMUNOTHERAPY;
BIOTECHNOLOGY;
CARCINOGENICITY;
CONFERENCE PAPER;
GENE TRANSFER;
GENOTOXICITY;
IMMUNOGENICITY;
MEDICAL PRACTICE;
ORGAN TRANSPLANTATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REPRODUCTIVE TOXICITY;
RISK ASSESSMENT;
TISSUE GRAFT;
BIOTECHNOLOGY;
HUMANS;
NEOPLASMS;
REPRODUCTION;
RISK ASSESSMENT;
SAFETY;
|
EID: 0035977920
PISSN: 03784274
EISSN: None
Source Type: Journal
DOI: 10.1016/S0378-4274(01)00310-1 Document Type: Conference Paper |
Times cited : (19)
|
References (8)
|